I noticed in one chart a comparison was made between Emerade, EpiPen and Jext. I couldn't find much about Jext other than their main presence but it looks like it shares form factor with an EpiPen.

uv protection would be one guess.

The others are:

a) possible extended dosing evaluation-- recall, Dey/Mylan doesn't exactly have a profit motive for testing efficacy/degradation out past expiry.  My guess is that they haven't.  There's just not much literature on the subject either way-- and yet people routinely store them in high heat and then report some efficacy even with devices which are YEARS out of date, so...

b) proprietary buffering with redox scavengers-- but this one is something of a long shot, IMO.  They might degass buffering solutions with nitrogen or even with a noble gas, though-- and that might really make a HUGE difference when coupled with excellent UV protection.

There is no upper temperature restriction.

WOW.


That looks like a GREAT device, Eragon.  I'm openly envious, now.

http://www.emerade.com/hcp/adrenaline-auto-injector